325 related articles for article (PubMed ID: 20573821)
21. Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters.
Ramachandran S; Knickelbein JE; Ferko C; Hendricks RL; Kinchington PR
Virology; 2008 Sep; 378(2):254-64. PubMed ID: 18619637
[TBL] [Abstract][Full Text] [Related]
22. Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency.
Reddy PB; Sehrawat S; Suryawanshi A; Rajasagi NK; Mulik S; Hirashima M; Rouse BT
J Immunol; 2011 Dec; 187(11):5745-55. PubMed ID: 22021615
[TBL] [Abstract][Full Text] [Related]
23. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons.
Liu T; Khanna KM; Chen X; Fink DJ; Hendricks RL
J Exp Med; 2000 May; 191(9):1459-66. PubMed ID: 10790421
[TBL] [Abstract][Full Text] [Related]
24. Medroxyprogesterone acetate inhibits CD8+ T cell viral-specific effector function and induces herpes simplex virus type 1 reactivation.
Cherpes TL; Busch JL; Sheridan BS; Harvey SA; Hendricks RL
J Immunol; 2008 Jul; 181(2):969-75. PubMed ID: 18606648
[TBL] [Abstract][Full Text] [Related]
25. Lymphocytes delay kinetics of HSV-1 reactivation from in vitro explants of latent infected trigeminal ganglia.
Noisakran S; Carr DJ
J Neuroimmunol; 1999 Mar; 95(1-2):126-35. PubMed ID: 10229122
[TBL] [Abstract][Full Text] [Related]
26. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons.
Liu T; Khanna KM; Carriere BN; Hendricks RL
J Virol; 2001 Nov; 75(22):11178-84. PubMed ID: 11602757
[TBL] [Abstract][Full Text] [Related]
27. Level of herpes simplex virus type 1 latency correlates with severity of corneal scarring and exhaustion of CD8+ T cells in trigeminal ganglia of latently infected mice.
Mott KR; Bresee CJ; Allen SJ; BenMohamed L; Wechsler SL; Ghiasi H
J Virol; 2009 Mar; 83(5):2246-54. PubMed ID: 19091870
[TBL] [Abstract][Full Text] [Related]
28. Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice.
Ghiasi H; Perng G; Nesburn AB; Wechsler SL
Microb Pathog; 1999 Dec; 27(6):387-94. PubMed ID: 10588911
[TBL] [Abstract][Full Text] [Related]
29. Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.
Matundan H; Mott KR; Ghiasi H
J Virol; 2014 Jul; 88(14):8016-27. PubMed ID: 24807710
[TBL] [Abstract][Full Text] [Related]
30. In vivo reactivation of latent herpes simplex virus 1 in mice can occur in the brain before occurring in the trigeminal ganglion.
Yao HW; Ling P; Tung YY; Hsu SM; Chen SH
J Virol; 2014 Oct; 88(19):11264-70. PubMed ID: 25031345
[TBL] [Abstract][Full Text] [Related]
31. Bolstering the Number and Function of HSV-1-Specific CD8
Khan AA; Srivastava R; Chentoufi AA; Kritzer E; Chilukuri S; Garg S; Yu DC; Vahed H; Huang L; Syed SA; Furness JN; Tran TT; Anthony NB; McLaren CE; Sidney J; Sette A; Noelle RJ; BenMohamed L
J Immunol; 2017 Jul; 199(1):186-203. PubMed ID: 28539429
[TBL] [Abstract][Full Text] [Related]
32. Broadening the repertoire of functional herpes simplex virus type 1-specific CD8+ T cells reduces viral reactivation from latency in sensory ganglia.
St Leger AJ; Jeon S; Hendricks RL
J Immunol; 2013 Sep; 191(5):2258-65. PubMed ID: 23878317
[TBL] [Abstract][Full Text] [Related]
33. Presence of HSV-1 immediate early genes and clonally expanded T-cells with a memory effector phenotype in human trigeminal ganglia.
Derfuss T; Segerer S; Herberger S; Sinicina I; Hüfner K; Ebelt K; Knaus HG; Steiner I; Meinl E; Dornmair K; Arbusow V; Strupp M; Brandt T; Theil D
Brain Pathol; 2007 Oct; 17(4):389-98. PubMed ID: 17784877
[TBL] [Abstract][Full Text] [Related]
34. ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells.
Halford WP; Kemp CD; Isler JA; Davido DJ; Schaffer PA
J Virol; 2001 Jul; 75(13):6143-53. PubMed ID: 11390616
[TBL] [Abstract][Full Text] [Related]
35. The early expression of glycoprotein B from herpes simplex virus can be detected by antigen-specific CD8+ T cells.
Mueller SN; Jones CM; Chen W; Kawaoka Y; Castrucci MR; Heath WR; Carbone FR
J Virol; 2003 Feb; 77(4):2445-51. PubMed ID: 12551982
[TBL] [Abstract][Full Text] [Related]
36. Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.
Ghiasi H; Osorio Y; Hedvat Y; Perng GC; Nesburn AB; Wechsler SL
Virology; 2002 Oct; 302(1):144-54. PubMed ID: 12429523
[TBL] [Abstract][Full Text] [Related]
37. Interrelationship of Primary Virus Replication, Level of Latency, and Time to Reactivation in the Trigeminal Ganglia of Latently Infected Mice.
Matundan HH; Mott KR; Allen SJ; Wang S; Bresee CJ; Ghiasi YN; Town T; Wechsler SL; Ghiasi H
J Virol; 2016 Oct; 90(20):9533-42. PubMed ID: 27512072
[TBL] [Abstract][Full Text] [Related]
38. CD8+ T Cells Play a Bystander Role in Mice Latently Infected with Herpes Simplex Virus 1.
Mott KR; Gate D; Matundan HH; Ghiasi YN; Town T; Ghiasi H
J Virol; 2016 May; 90(10):5059-5067. PubMed ID: 26962220
[TBL] [Abstract][Full Text] [Related]
39. Diminished secondary CTL response in draining lymph nodes on cutaneous challenge with herpes simplex virus.
Jones CM; Cose SC; McNally JM; Jennings SR; Heath WR; Carbone FR
J Gen Virol; 2000 Feb; 81(Pt 2):407-14. PubMed ID: 10644839
[TBL] [Abstract][Full Text] [Related]
40. Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo.
Halford WP; Schaffer PA
J Virol; 2000 Jul; 74(13):5957-67. PubMed ID: 10846077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
